These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15627288)

  • 1. T Cell-specific immunosuppression using tautomycetin or PTD-conjugated protein drugs.
    Chae WJ; Choi JM; Yang JJ; Lee SK
    Yonsei Med J; 2004 Dec; 45(6):978-90. PubMed ID: 15627288
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressive effects of tautomycetin in vivo and in vitro via T cell-specific apoptosis induction.
    Shim JH; Lee HK; Chang EJ; Chae WJ; Han JH; Han DJ; Morio T; Yang JJ; Bothwell A; Lee SK
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10617-22. PubMed ID: 12149481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new antibiotic, tautomycetin.
    Cheng XC; Kihara T; Ying X; Uramoto M; Osada H; Kusakabe H; Wang BN; Kobayashi Y; Ko K; Yamaguchi I
    J Antibiot (Tokyo); 1989 Jan; 42(1):141-4. PubMed ID: 2921220
    [No Abstract]   [Full Text] [Related]  

  • 4. Workshop on immunosuppression by biologic methods.
    Levey RH
    Transplant Proc; 1979 Mar; 11(1):1179-82. PubMed ID: 313096
    [No Abstract]   [Full Text] [Related]  

  • 5. Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma.
    Batchu RB; Moreno AM; Szmania SM; Bennett G; Spagnoli GC; Ponnazhagan S; Barlogie B; Tricot G; van Rhee F
    Cancer Res; 2005 Nov; 65(21):10041-9. PubMed ID: 16267030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression following cardiac transplantation.
    Copeland JG; Emery RW; Levinson MM; Icenogle T
    Contemp Anesth Pract; 1987; 10():233-40. PubMed ID: 3555997
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of T & B cell dependent immune systems in chicken.
    Gupta SK; Kharole MU; Kalra DS
    Indian J Exp Biol; 1982 Mar; 20(3):200-3. PubMed ID: 6981597
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence that initial T cell depletion suppresses antiantibody formation and preserves immunosuppression after polyclonal ATG.
    Thienfelder S; Hoffmann-Fezer G; Kremmer E
    Transplantation; 1989 Sep; 48(3):511-4. PubMed ID: 2571208
    [No Abstract]   [Full Text] [Related]  

  • 9. New trends in non-antigen-specific immunosuppression.
    Bach JF
    Transplant Proc; 1979 Mar; 11(1):851-4. PubMed ID: 313107
    [No Abstract]   [Full Text] [Related]  

  • 10. Rethinking immunosuppression in terms of the redundant and nonredundant steps in the immune response.
    Halloran PF
    Transplant Proc; 1996 Dec; 28(6 Suppl 1):11-8. PubMed ID: 8962408
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of dendritic cell costimulation associated with tolerance to allografts.
    Adorini L
    Eur Cytokine Netw; 2000 Sep; 11(3):508-9. PubMed ID: 11203197
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic manipulation: specific mechanisms.
    Brent L
    Transplant Proc; 1979 Mar; 11(1):839-44. PubMed ID: 313106
    [No Abstract]   [Full Text] [Related]  

  • 13. On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs.
    Bae HD; Lee K
    J Control Release; 2013 Sep; 170(3):358-64. PubMed ID: 23791976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreas transplant outcome with or without biological anti-T-cell therapy for induction immunosuppression with use of cyclosporine.
    Sutherland DE; Moudry-Munns KC; Gruessner A
    Transplant Proc; 1994 Oct; 26(5):2752-5. PubMed ID: 7940866
    [No Abstract]   [Full Text] [Related]  

  • 15. [Perspectives of immunosuppressive therapy].
    Meuer S; Sido B; Dengler T
    Chirurg; 1996 Apr; 67(4):310-7. PubMed ID: 8646915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing T cell activation and antiviral protection by introducing the HIV-1 protein transduction domain into a DNA vaccine.
    Leifert JA; Lindencrona JA; Charo J; Whitton JL
    Hum Gene Ther; 2001 Oct; 12(15):1881-92. PubMed ID: 11589830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells in renal transplantation and modulation by immunosuppression.
    López-Hoyos M; Segundo DS; Fernández-Fresnedo G; Marín MJ; González-Martín V; Arias M
    Transplantation; 2009 Aug; 88(3 Suppl):S31-9. PubMed ID: 19667959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTD-mediated intracellular delivery of mutant NFAT minimum DNA binding domain inhibited the proliferation of T cells.
    Liu X; Zhao Q; Peng X; Xia S; Shen W; Zong Y; Cheng J; Wu W; Zhang M; Du F; Xu W; Qian H; Shao Q
    Int Immunopharmacol; 2014 Mar; 19(1):110-8. PubMed ID: 24440534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells transduced with TAT protein transduction domain-containing tyrosinase-related protein 2 vaccinate against murine melanoma.
    Shibagaki N; Udey MC
    Eur J Immunol; 2003 Apr; 33(4):850-60. PubMed ID: 12672050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tautomycetin on proliferation and fibronectin secretion in vascular smooth muscle cells and glomerular mesangial cells.
    Kim JH; Lee TY; Park J; Ha H; Kang SW; Kim YS
    Transplant Proc; 2005 May; 37(4):1959-61. PubMed ID: 15919517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.